201 filings
Page 9 of 11
6-K
pj6i4b3ip 7j
11 Jan 18
Current report (foreign)
12:00am
6-K
tnidlrgzjyo
8 Jan 18
Current report (foreign)
12:00am
DRS
800k8sx fws4exvz
22 Dec 17
Draft registration statement
12:00am
6-K
48hfs1ktf9uyj2dqw
14 Dec 17
UroGen Pharma Expands Clinical Development Leadership Team
12:00am
6-K
6vzxat11 ytfwneh9j
14 Nov 17
Current report (foreign)
12:00am
6-K
42c5l6fzmpnuxjr62wf
7 Nov 17
UroGen Pharma Announces First Patient Enrolled in Allergan Phase 2 Clinical
12:00am
6-K
8glea950j
2 Nov 17
UroGen Pharma Appoints Former Kite Pharma Chief Operating Officer Cynthia M. Butitta to its Board of Directors
12:00am
S-8
57iy9
30 Oct 17
Registration of securities for employees
12:00am
6-K
jyux tj4xh87vv
29 Aug 17
Current report (foreign)
12:00am
6-K
l2c70sdgte
14 Aug 17
Current report (foreign)
12:00am
6-K
ag6rbiwscwht
19 Jul 17
Current report (foreign)
12:00am
S-8
eak3yrtmwwxc28h7eb0n
27 Jun 17
Registration of securities for employees
12:00am
6-K
vdj1rmm 2r2blpz
18 May 17
UroGen Pharma Appoints Fred E. Cohen, MD, to its Board of Directors
12:00am
424B4
tz7riib
5 May 17
Prospectus supplement with pricing info
12:00am
CT ORDER
kv06q suirypz9
4 May 17
Confidential treatment order
12:00am
EFFECT
ajk1d
3 May 17
Notice of effectiveness
12:00am
F-1MEF
ix3yt1g fg1
3 May 17
Registration statement to add securities to prior F-1 registration
12:00am
CORRESP
ngmpre itvl2nf
1 May 17
Correspondence with SEC
12:00am
8-A12B
cbl 98rwtgpi
1 May 17
Registration of securities on exchange
12:00am
CORRESP
08sk979u
1 May 17
Correspondence with SEC
12:00am